User profiles for "author:Michael Iroezindu"

Michael O. Iroezindu

Senior Lecturer in Infectious/Tropical Diseases, HIV Medicine and Internal Medicine …
Verified email at unn.edu.ng
Cited by 1558

Clinical course and outcome of human monkeypox in Nigeria

D Ogoina, M Iroezindu, HI James… - Clinical Infectious …, 2020 - academic.oup.com
In a retrospective review of hospital records of 40 human monkeypox cases from Nigeria, the
majority developed fever and self-limiting vesiculopustular skin eruptions. Five deaths were …

[HTML][HTML] Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time

KG Barnes, AE Lachenauer, A Nitido, S Siddiqui… - Nature …, 2020 - nature.com
Recent outbreaks of viral hemorrhagic fevers (VHFs), including Ebola virus disease (EVD)
and Lassa fever (LF), highlight the urgent need for sensitive, deployable tests to diagnose …

[PDF][PDF] Prevalence and risk factors for opportunistic infections in HIV patients receiving antiretroviral therapy in a resource-limited setting in Nigeria.

MO Iroezindu, EO Ofondu, H Hausler, BV Wyk - 2013 - researchgate.net
Prevalence and Risk Factors for Opportunistic Infections in HIV Patients Receiving Antiretroviral
Therapy in a Resource-Limited Page 1 Open Access Research article Iroezindu et al., J AIDS …

[HTML][HTML] A national survey of hospital readiness during the COVID-19 pandemic in Nigeria

D Ogoina, D Mahmood, AS Oyeyemi, OC Okoye… - PLoS …, 2021 - journals.plos.org
Introduction The COVID-19 pandemic continues to overwhelm health systems across the
globe. We aimed to assess the readiness of hospitals in Nigeria to respond to the COVID-19 …

Weight gain during the dolutegravir transition in the African Cohort Study

AL Esber, D Chang, M Iroezindu… - Journal of the …, 2022 - Wiley Online Library
Introduction Dolutegravir (DTG) has become a preferred component of first‐line antiretroviral
therapy (ART) in many settings but may be associated with excess weight gain. We …

Pretreatment and acquired antiretroviral drug resistance among persons living with HIV in four African countries

TA Crowell, B Danboise, A Parikh… - Clinical Infectious …, 2021 - academic.oup.com
Background Emerging HIV drug resistance (HIVDR) could jeopardize the success of
standardized HIV management protocols in resource-limited settings. We characterized …

[HTML][HTML] Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria

OK Oloniniyi, US Unigwe, S Okada… - PLoS neglected …, 2018 - journals.plos.org
Lassa virus (LASV) is endemic in parts of West Africa where it causes Lassa fever (LF), a
viral hemorrhagic fever with frequent fatal outcomes. The diverse LASV strains are grouped …

[HTML][HTML] Prevalence and risk factors associated with HIV and syphilis co-infection in the African Cohort Study: a cross-sectional study

L Gilbert, N Dear, A Esber, M Iroezindu… - BMC Infectious …, 2021 - Springer
Abstract Background Each year, 5.6 million new syphilis cases are diagnosed globally.
Guidelines for people living with HIV (PLWH) in low-income countries (LIC) recommend STI …

Non‐communicable diseases by age strata in people living with and without HIV in four African countries

D Chang, AL Esber, NF Dear… - Journal of the …, 2022 - Wiley Online Library
Abstract Introduction Non‐communicable diseases (NCDs) are an important driver of
morbidity among ageing people living with HIV (PLWH). We examined the composite role of …

Predictors of all-cause mortality among people with human immunodeficiency virus (HIV) in a prospective cohort study in east Africa and Nigeria

H Kibuuka, E Musingye, B Mwesigwa… - Clinical Infectious …, 2022 - academic.oup.com
Background Introduction of antiretroviral therapy (ART) has been associated with a decline
in human immunodeficiency virus (HIV)-related mortality, although HIV remains a leading …